513 related articles for article (PubMed ID: 11496243)
1. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
Paul ME; Shearer WT; Kozinetz CA; Lewis DE
J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
[TBL] [Abstract][Full Text] [Related]
2. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
3. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
Choremi-Papadopoulou H; Tsalimalma K; Dafni U; Dimitracopoulou A; Kordossis T
J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
[TBL] [Abstract][Full Text] [Related]
4. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E
Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270
[TBL] [Abstract][Full Text] [Related]
5. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O; Holub M; Spála J; Kalanin J; Stanková M
Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
[TBL] [Abstract][Full Text] [Related]
6. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
7. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
8. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
10. Progressive infection in a subset of HIV-1-positive chimpanzees.
O'Neil SP; Novembre FJ; Hill AB; Suwyn C; Hart CE; Evans-Strickfaden T; Anderson DC; deRosayro J; Herndon JG; Saucier M; McClure HM
J Infect Dis; 2000 Oct; 182(4):1051-62. PubMed ID: 10979899
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
12. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
[TBL] [Abstract][Full Text] [Related]
13. CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy.
Resino S; Bellón JM; Gurbindo MD; Muñoz-Fernández MA
Clin Infect Dis; 2004 Feb; 38(3):412-7. PubMed ID: 14727214
[TBL] [Abstract][Full Text] [Related]
14. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.
Paul ME; Mao C; Charurat M; Serchuck L; Foca M; Hayani K; Handelsman EL; Diaz C; McIntosh K; Shearer WT;
J Allergy Clin Immunol; 2005 Apr; 115(4):848-55. PubMed ID: 15806009
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
16. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.
Liu Z; Hultin LE; Cumberland WG; Hultin P; Schmid I; Matud JL; Detels R; Giorgi JV
Cytometry; 1996 Mar; 26(1):1-7. PubMed ID: 8809474
[TBL] [Abstract][Full Text] [Related]
17. [T-cell subsets variation during clinical and immunological progression in vertically HIV-infected children].
Resino García S; Bellón Cano JM; Navarro Caspistegui J; Gurbindo Gutiérrez D; León Leal JA; Muñoz-Fernández MA
Medicina (B Aires); 2001; 61(5 Pt 1):557-65. PubMed ID: 11721322
[TBL] [Abstract][Full Text] [Related]
18. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y
J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic patterns of CD8+ T cell subsets expressing CD8alphaalpha and IL-7Ralpha in viremic, aviremic and slow progressor HIV-1-infected subjects.
Boulassel MR; Mercier F; Gilmore N; Routy JP
Clin Immunol; 2007 Aug; 124(2):149-57. PubMed ID: 17560832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
